Negative impactOrders & Deals
Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore
Economic Times 2 hrs ago·9 Oct 2026, 4:23 pm
Anthem Biosciences saw a significant block deal on October 9, with Portsmouth Technologies selling 30 lakh shares. This transaction was executed at Rs 833 per share, resulting in a total value of approximately Rs 250 crore. Following this sale, Portsmouth's ownership stake in the company is expected to decrease substantially.
For investors, this large-scale divestment is a key development to monitor. It signals a potential shift in the company's shareholder base and could influence the stock's short-term price movement. Investors should also pay attention to the company's quarterly performance, as Anthem recently reported a decline in total income and profit after tax for the first quarter of FY27.
Moving forward, the focus should be on how the stock reacts to this change in ownership and the company's ability to stabilize its financial performance in the coming quarters.
Excerpt from Economic Times
Portsmouth Technologies LLC executed a block deal selling 30 lakh shares of Anthem Biosciences on October 9. The shares were sold at Rs 833 each, totaling Rs 249.90 crore. Following this transaction, Portsmouth's estimated stake in the company would decrease significantly. Anthem Biosciences reported a decline in…Read the original at Economic Times
Affected stocks
Bearish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Anthem Biosciences (ANTHEM).
- Category: Orders & Deals.
- AI reads the tone as negative (potentially bearish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Anthem Biosciences worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
